{"id":37035,"date":"2025-07-09T15:49:28","date_gmt":"2025-07-09T07:49:28","guid":{"rendered":"https:\/\/flcube.com\/?p=37035"},"modified":"2025-07-09T15:49:29","modified_gmt":"2025-07-09T07:49:29","slug":"pascal-qian-appointed-general-manager-of-bms-china-unit","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=37035","title":{"rendered":"Pascal Qian Appointed General Manager of BMS China Unit"},"content":{"rendered":"\n<p>Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; <a href=\"https:\/\/www.google.com\/finance\/quote\/BMY:NYSE\">NYSE: BMY<\/a>) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.<\/p>\n\n\n\n<p><strong>Experience and Achievements<\/strong><br>Qian\u2019s extensive experience in the pharmaceutical industry includes significant contributions to the market entry of multiple drugs in China. His efforts in securing NRDL listings have enhanced patient access to critical medications. His leadership roles at various multinational pharmaceutical companies have equipped him with the skills and insights necessary to drive BMS\u2019s growth in the Chinese market.<\/p>\n\n\n\n<p><strong>Future Plans<\/strong><br>Qian has already been with BMS for 18 months prior to this promotion. Looking ahead, he aims to accelerate the localization of innovative therapies in China. This strategic focus will play a crucial role in expanding BMS\u2019s presence and impact within the Chinese pharmaceutical market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":37039,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[429,428,199,120,1524,140,849,309,163],"class_list":["post-37035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-bms","tag-bristol-myers-squibb","tag-eli-lilly","tag-merck","tag-nasdaq-lian","tag-novartis","tag-nyse-bmy","tag-pfizer","tag-roche"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pascal Qian Appointed General Manager of BMS China Unit - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; NYSE: BMY) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=37035\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pascal Qian Appointed General Manager of BMS China Unit\" \/>\n<meta property=\"og:description\" content=\"Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; NYSE: BMY) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=37035\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-09T07:49:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-09T07:49:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Pascal Qian Appointed General Manager of BMS China Unit\",\"datePublished\":\"2025-07-09T07:49:28+00:00\",\"dateModified\":\"2025-07-09T07:49:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035\"},\"wordCount\":209,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0912.webp\",\"keywords\":[\"BMS\",\"Bristol-Myers Squibb\",\"Eli Lilly\",\"Merck\",\"NASDAQ: LIAN\",\"Novartis\",\"NYSE: BMY\",\"Pfizer\",\"Roche\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37035#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=37035\",\"name\":\"Pascal Qian Appointed General Manager of BMS China Unit - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0912.webp\",\"datePublished\":\"2025-07-09T07:49:28+00:00\",\"dateModified\":\"2025-07-09T07:49:29+00:00\",\"description\":\"Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; NYSE: BMY) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37035\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0912.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0912.webp\",\"width\":1080,\"height\":608,\"caption\":\"Pascal Qian Appointed General Manager of BMS China Unit\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37035#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pascal Qian Appointed General Manager of BMS China Unit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pascal Qian Appointed General Manager of BMS China Unit - Insight, China&#039;s Pharmaceutical Industry","description":"Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; NYSE: BMY) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=37035","og_locale":"en_US","og_type":"article","og_title":"Pascal Qian Appointed General Manager of BMS China Unit","og_description":"Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; NYSE: BMY) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.","og_url":"https:\/\/flcube.com\/?p=37035","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-09T07:49:28+00:00","article_modified_time":"2025-07-09T07:49:29+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=37035#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=37035"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Pascal Qian Appointed General Manager of BMS China Unit","datePublished":"2025-07-09T07:49:28+00:00","dateModified":"2025-07-09T07:49:29+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=37035"},"wordCount":209,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=37035#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp","keywords":["BMS","Bristol-Myers Squibb","Eli Lilly","Merck","NASDAQ: LIAN","Novartis","NYSE: BMY","Pfizer","Roche"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=37035#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=37035","url":"https:\/\/flcube.com\/?p=37035","name":"Pascal Qian Appointed General Manager of BMS China Unit - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=37035#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=37035#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp","datePublished":"2025-07-09T07:49:28+00:00","dateModified":"2025-07-09T07:49:29+00:00","description":"Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb\u2019s (BMS; NYSE: BMY) China unit. With over 20 years of leadership experience in multinational pharmaceutical companies, Qian brings a proven track record from roles at Roche, Merck, Pfizer, Novartis, and Eli Lilly. At Pfizer and Lilly, he successfully led the market entry of several blockbuster drugs in China and secured listings on the National Reimbursement Drug List (NRDL). Before joining BMS, Qian served as China General Manager and Chief Commercial Officer at LianBio.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=37035#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=37035"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=37035#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp","width":1080,"height":608,"caption":"Pascal Qian Appointed General Manager of BMS China Unit"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=37035#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Pascal Qian Appointed General Manager of BMS China Unit"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0912.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37035"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37035\/revisions"}],"predecessor-version":[{"id":37040,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37035\/revisions\/37040"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/37039"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}